HOME >> BIOLOGY >> NEWS
Florida Tech researchers win $912,700 grant for cell studies

MELBOURNE, FLA.--Florida Tech researchers, studying the regulatory mechanisms of cell growth, were awarded a $912,700 National Institutes of Health grant for four years. The grant period starts May 1, 2004.

Dr. Alan C. Leonard, professor of biological sciences, and Dr. Julia Grimwade, associate professor of biological sciences, were awarded the funding, which furthers their efforts to understand the genetic switches that trigger the reproduction of the bacterium Escherichia coli.

"One of the fundamental problems in biology is to understand how cell growth is regulated," said Leonard. "We think of the inner workings of the cell as machinery and some of the machines need to be switched on at a specific time for the cell to reproduce" Studies in the Leonard/Grimwade laboratories have led to the identification of key pieces of the switch. Understanding their role will shed new light on controlling bacterial growth and perhaps aid in the understanding of abnormal cell growth seen in cancer.

An ultimate goal of the Leonard and Grimwade's research is to use the information obtained from studies of bacterial cell growth to produce inhibitors--novel antibiotics--that would enter the bacteria and prevent critical switch components from completing their interactions. This would impact a variety of human diseases caused by pathogenic bacteria.

"At Florida Tech we have grown into one of the world's leading laboratories for the study of cell growth," said Leonard. "Our work combines studies of living bacteria with biochemical studies of purified cellular components interacting in a test tube. Test tube studies are easier to perform, but don't always reflect real life. Our advantage is that we have developed unique methods to evaluate what is actually happening inside a living cell to prove the validity of our biochemical measurements and the measurements made in other laboratories."

Working with Leonard and Grimwade are doctoral students,
'"/>

Contact: Karen Rhine
krhine@fit.edu
321-674-8964
Florida Institute of Technology
15-Apr-2004


Page: 1 2

Related biology news :

1. Tracing genes, biologists show lizard migration is traced to Florida
2. Florida Tech earns $50,000 grant to create coral database
3. Florida frontier expedition
4. Exploring the sights and sounds of a deepwater coral marine protected area off Florida
5. Black water turns the tide on Florida coral
6. UCF to host Florida Academy of Sciences meeting
7. Coral smothering green tide seaweed spreading on Florida reefs
8. University of Florida engineers probe shape memory alloy for better prostheses
9. Common bacteria kills elkhorn coral off Florida keys, says UGA research team
10. University of South Florida team conducts trial for HIV vaccine
11. People and fire at Floridas wildland-urban interface

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Florida Tech researchers win grant for cell studies

(Date:3/17/2015)... Minn. , March 17, 2015 ... technology company specializing in clinical study management systems, ... be in attendance at ARENA,s Outsourcing in Clinical ... NC.  This event provides an excellent forum for ... easy-to-use, flexible and affordable software-as-a-service (SaaS) eClinical technology ...
(Date:3/12/2015)... , March 12, 2015 The mascots of ... Children,s Hospital, part of Wake Forest Baptist Medical Center. ... for the 2015 ACC Men,s Basketball Tournament. Young patients ... them and getting their autographs. Brenner Children,s ... It is the only children,s hospital in northwest ...
(Date:3/10/2015)... 2015  Continuing its 167-year history of offering the ... The Eye Scanning Password Authenticator , a device ... secure websites or sensitive data. Employing the ... borders, the device has a small camera that scans ... iris, converting them into an encrypted ID that cannot ...
Breaking Biology News(10 mins):Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2
(Date:3/25/2015)... 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") ... of recent discussions with certain shareholders representing approximately 45% ... after dealing with certain matters including the appointment of ... on March 26, 2015 (the "Meeting") it intends to ... will take place when the Meeting reconvenes. The Meeting ...
(Date:3/25/2015)... 25, 2015  S&P Capital IQ (MHFI) announced ... Report coverage on Abattis Bioceuticals Corp . ... is a specialty biotechnology company with capabilities through ... marketing proprietary ingredients, bio-similar compounds, patented equipment and ... North America . The company seeks to ...
(Date:3/25/2015)... , CAMBRIDGE, Mass. and ... NextCODE, which provides comprehensive capabilities for using the genome to ... on their publication of the largest studies of whole-genome data ... online in Nature Genetics – are ... sequence variation, authored by a team of deCODE scientists led ...
(Date:3/25/2015)... CA (PRWEB) March 25, 2015 ... for Novel Mechanism of Action in Neuromuscular Diseases ... 2015 – Cytokinetics, Incorporated (Nasdaq: CYTK) announced the ... skeletal muscle troponin activator tirasemtiv in the journal ... Phase IIa “Evidence of Effect” or hypothesis-generating clinical ...
Breaking Biology Technology:SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 2SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 3SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 4SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 5S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 5Landmark deCODE Studies Demonstrate the Power of Truly Big Genomics for Improving Medicine Worldwide 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 6
Cached News: